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Background: Cutaneous Leishmaniasis (CL) in Afghanistan is
ndemic. Kabul is the world capital of this disease, reporting more
han 40% of the total annual incidence. However, under-reporting
isleads the real burden: for each detected case, the primary
ealthcare system misses 3-5 cases. This NTD has the following
ain impacts:i) stigma and marginalization due to the permanent
isabilities (particularly facial disﬁguration); ii) qualityof life, as the
urationof CL is not just limited to theperiodof the active infection,
ut can have a life long effect as for disﬁguration and disabilities.
njections of antimonite (SSG) remain the ﬁrst line drug available
n Afghanistan. The national leishmaniasis control program is inte-
rated with malaria and WHO is the only partner supporting the
trategic and operational needs. The proposed presentation illus-
rates the impact generated upon a 2-year intervention in southern
egion and Kabul city, with the aim to strengthen the surveillance
ystem.
Methods: Intervention project to increase and strengthen the
L surveillance system, based on the past epidemiological trends
nd endemicity levels. Applied interventions:
) Inter-program integration for surveillance with the national
malaria program.
) Design and application for the ﬁrst time ever in Afghanistan
of data reporting forms illustrating treatment outcomes. These
forms have been distributed through the public health facilities
operating at the primary health level in Afghanistan (Basic Pack-
age of Health Services - BPHS implementers) over one year and
half, for pilot and ﬁrst assessment.
) Capacity building of approximately 120 national health work-
ers at BPHS level about correct case detection, diagnosis and
reporting.
Results:
) Increased by 50% the detection rate.
) Detected the number of failure and relapses cases, standing as
approx 30% of the covered population.
) 50% increase of detected VL cases.
Conclusion: The introduction of the revised reporting forms,
ombined with the expansion of the CL and VL program cover-
ge, overall, resulted into: i) increasing the accessibility to effective
iagnosis and treatment; ii) reducing the number of cases misdiag-
osed; iii) rationalizing the use of leishmaniasis treatment drugs.The integration with the malaria program enabled to establish
conomies of scale, thus resulting into cost-effective interventions.
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Potential adverseoutcomesofmaintenance intravenousﬂuid in
adult dengue without plasma leakage: an observational cohort
study
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Background: Randomised studies document the effectiveness
of intravenous ﬂuid resuscitation for dengue shock syndrome in
children. The World Health Organisation 2009 dengue guidelines
recommend maintenance intravenous ﬂuid for dengue patients
with warning signs. Studies supporting this recommendation for
dengue patients without plasma leakage are lacking.
Methods: We reviewed medical records for 1529 adult inpa-
tients without dengue haemorrhagic fever (DHF) or severe dengue
(SD) at presentation to Tan Tock Seng Hospital, Singapore, from
2006 to 2008 to assess the effect of maintenance intravenous ﬂuid
on the subsequent development of DHF, SD and length of hos-
pitalisation. We adjusted for 98 potential demographic, clinical
and laboratory confounders using generalised linear models ﬁt
using L1-regularisation paths to explore the model space and cross
validation to identify optimal model complexity, withholding the
treatment variable until the ﬁnal stage of analysis.
Results: Warning signs occurred in 961 (63%). After hospitalisa-
tion, DHF occurred in 248 (16%) and SD in 122 (8%). The median
daily intravenous ﬂuid volume administered among those who
received it was 3500ml (interquartile range [IQR], 3050–7000ml)
and the median duration of intravenous ﬂuid therapy was three
days (IQR three–ﬁve days). There was no evidence of an effect
of maintenance intravenous ﬂuid on the development of DHF
(adjusted odds ratio [aOR] 1.4, 95% conﬁdence interval [CI] 0.75,
2.80, p=0.27), and suggestive evidence that it was associated with
an increased risk of progressing to severe dengue (aOR 3.6, 95%CI
1.1, 12.0, p=0.040). Intravenous ﬂuid receipt was associated with a
marginal increase in length of hospitalisation (median ratio 1.11,
95%CI 1.06, 1.16, p<0.0001). A single-centre randomised clinical
trial with 400 patients on each arm would be well powered to
demonstrate deﬁnitively whether intravenous ﬂuid of patients
with dengue fever increases the risk of developing severe dengue,
in our predominantly adult setting.
Conclusion:Adult patientswithout baseline evidence of plasma
leakageor signiﬁcant volumedepletionmaynot beneﬁt frommain-
tenance intravenous ﬂuid therapy if they can retain and absorb
oral ﬂuid. This study suggests a randomised clinical trial of main-http://dx.doi.org/10.1016/j.ijid.2012.05.093
